82 FR 12821 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 82, Issue 43 (March 7, 2017)
Centers for Disease Control and Prevention
Federal Register Volume 82, Issue 43 (March 7, 2017)
| Page Range | 12821-12821 | |
| FR Document | 2017-04354 |
[Federal Register Volume 82, Number 43 (Tuesday, March 7, 2017)] [Notices] [Page 12821] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-04354] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) DP15-0020301SUPP17, Supplement to Enhance Laboratory and Statistical Support of the Population Registry of Diabetes in Youth. TIME AND DATE: 11:00 a.m.-2:00 p.m., EDT, March 29, 2017 (Closed). PLACE: Teleconference. STATUS: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463. MATTERS FOR DISCUSSION: The meeting will include the initial review, discussion, and evaluation of applications received in response to ``Supplement to Enhance Laboratory and Statistical Support of the Population Registry of Diabetes in Youth'', FOA DP15-0020301SUPP17. CONTACT PERSON FOR MORE INFORMATION: Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488-6511, [email protected] delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017-04354 Filed 3-6-17; 8:45 am] BILLING CODE 4163-18-P
![Federal Register / Vol. 82, No. 43 / Tuesday, March 7, 2017 / Notices 12821
NAS [2010]. Chapter 7: peracetic acid-acute Officer, CDC, 4770 Buford Highway, Dated: March 1, 2017.
exposure guideline levels. In: acute Mailstop F80, Atlanta, Georgia 30341, Michelle Trout,
exposure guideline levels for selected Telephone: (770) 488–6511, kva5@
airborne chemicals: volume 8. [http:// Program Analyst, Office of Federal Advisory
cdc.gov delegated the authority to sign Committee Policy.
www.epa.gov/opptintr/aegl/pubs/
peracetic_acid_final_volume8_2010.pdf].
Federal Register notices pertaining to [FR Doc. 2017–04325 Filed 3–6–17; 8:45 am]
NIOSH (National Institute for Occupational announcements of meetings and other BILLING CODE 4140–01–P
Safety and Health) [draft 2015]. committee management activities, for
Immediately dangerous to life or health both the Centers for Disease Control and
(IDLH) value profile for peracetic acid. Prevention and the Agency for Toxic DEPARTMENT OF HEALTH AND
External review draft (Dated: March Substances and Disease Registry. HUMAN SERVICES
2015). [https://www.cdc.gov/niosh/
docket/review/docket156a/pdfs/g1-013- Elaine L. Baker,
National Institutes of Health
peracetic-acid-cas-79-21-0.pdf]. Director, Management Analysis and Services
Pechacek N, Osorio M, Caudill J, Peterson B Office, Centers for Disease Control and
[2015]. Evaluation of the toxicity data for
National Institute of Allergy and
Prevention.
peracetic acid in deriving occupational Infectious Diseases; Notice of Closed
[FR Doc. 2017–04354 Filed 3–6–17; 8:45 am] Meeting
exposure limits: A minireview.
BILLING CODE 4163–18–P
Toxicology Letters 233: 45–57.
Pursuant to section 10(d) of the
Dated: March 1, 2017.
Federal Advisory Committee Act, as
Frank Hearl, DEPARTMENT OF HEALTH AND amended (5 U.S.C. App.), notice is
Chief of Staff, National Institute for HUMAN SERVICES hereby given of the following meeting.
Occupational Safety and Health, Centers for
Disease Control and Prevention. National Institutes of Health The meeting will be closed to the
[FR Doc. 2017–04319 Filed 3–6–17; 8:45 am] public in accordance with the
BILLING CODE 4163–18–P National Center for Complementary provisions set forth in sections
and Integrative Health; Notice of 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Closed Meeting as amended. The grant applications and
DEPARTMENT OF HEALTH AND the discussions could disclose
HUMAN SERVICES Pursuant to section 10(d) of the confidential trade secrets or commercial
Federal Advisory Committee Act, as property such as patentable material,
Centers for Disease Control and amended (5 U.S.C. App.), notice is and personal information concerning
Prevention hereby given of the following meeting. individuals associated with the grant
The meeting will be closed to the applications, the disclosure of which
Disease, Disability, and Injury would constitute a clearly unwarranted
Prevention and Control Special public in accordance with the
provisions set forth in sections invasion of personal privacy.
Emphasis Panel (SEP): Initial Review
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Name of Committee: National Institute of
In accordance with Section 10(a)(2) of as amended. The grant applications and Allergy and Infectious Diseases Special
the Federal Advisory Committee Act the discussions could disclose Emphasis Panel; NIH Support for
(Pub. L. 92–463), the Centers for Disease confidential trade secrets or commercial Conferences and Scientific Meetings (Parent
Control and Prevention (CDC) property such as patentable material, R13).
announces a meeting for the initial and personal information concerning Date: March 20–22, 2017.
review of applications in response to individuals associated with the grant Time: 8:30 a.m. to 5:00 p.m.
Funding Opportunity Announcement Agenda: To review and evaluate grant
applications, the disclosure of which
applications.
(FOA) DP15–0020301SUPP17, would constitute a clearly unwarranted
Place: National Institutes of Health, 5601
Supplement to Enhance Laboratory and invasion of personal privacy. Fishers Lane, Rockville, MD 20892
Statistical Support of the Population Name of Committee: National Center for (Telephone Conference Call).
Registry of Diabetes in Youth. Complementary and Integrative Health Contact Person: J. Bruce Sundstrom, Ph.D.,
TIME AND DATE: 11:00 a.m.–2:00 p.m., Special Emphasis Panel; NIH Health Care Scientific Review Officer, Scientific Review
EDT, March 29, 2017 (Closed). Systems Research Collaboratory— Program, Division of Extramural Activities,
PLACE: Teleconference. Coordinating Center (U24). Room 3G11A, National Institutes of Health/
STATUS: The meeting will be closed to Date: April 6, 2017. NIAID, 5601 Fishers Lane, MSC 9823,
the public in accordance with Time: 12:00 p.m. to 2:00 p.m. Bethesda, MD 20892–9823, 240–669–5045,
provisions set forth in Section 552b(c) Agenda: To review and evaluate grant sundstromj@niaid.nih.gov.
(4) and (6), Title 5 U.S.C., and the applications. This notice is being published less than 15
Determination of the Director, Place: National Institutes of Health, Two days prior to the meeting due to the urgent
Democracy Plaza, 6707 Democracy need to meet timing limitations imposed by
Management Analysis and Services
Boulevard, Bethesda, MD 20892 (Virtual the intramural research review cycle.
Office, CDC, pursuant to Public Law 92–
Meeting). (Catalogue of Federal Domestic Assistance
463.
Contact Person: Viatcheslav A. Program Nos. 93.855, Allergy, Immunology,
MATTERS FOR DISCUSSION: The meeting Soldatenkov, Ph.D., Scientific Review and Transplantation Research; 93.856,
will include the initial review, Officer, Office of Scientific Review, Division Microbiology and Infectious Diseases
discussion, and evaluation of
sradovich on DSK3GMQ082PROD with NOTICES
of Extramural Activities, NCCIH/NIH, 6707 Research, National Institutes of Health, HHS)
applications received in response to Democracy Blvd., Suite 401, Bethesda, MD
‘‘Supplement to Enhance Laboratory Dated: March 1, 2017.
20892, 301–451–3849, sOLDATENKOVV@
and Statistical Support of the mail.nih.gov. Natasha M. Copeland,
Population Registry of Diabetes in (Catalogue of Federal Domestic Assistance Program Analyst, Office of Federal Advisory
Youth’’, FOA DP15–0020301SUPP17. Program Nos. 93.213, Research and Training Committee Policy.
CONTACT PERSON FOR MORE INFORMATION: in Complementary and Integrative Health, [FR Doc. 2017–04326 Filed 3–6–17; 8:45 am]
Jaya Raman Ph.D., Scientific Review National Institutes of Health, HHS) BILLING CODE 4140–01–P
VerDate Sep<11>2014 16:01 Mar 06, 2017 Jkt 241001 PO 00000 Frm 00040 Fmt 4703 Sfmt 9990 E:\FR\FM\07MRN1.SGM 07MRN1](https://thefederalregister.org/doc/82_FR_12864/page/1.svg)
Document Created: 2018-02-01 14:49:06
Document Modified: 2018-02-01 14:49:06
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | 11:00 a.m.-2:00 p.m., EDT, March 29, 2017 (Closed). | |
| FR Citation | 82 FR 12821 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR